Haima Therapeutics

Platelet-inspired platform technology for uncontrolled bleeding

Built from URL

HealthcarePharmaceuticals & MedicineDefenseMedical DevicesBiotech

MassChallengeTexas - Austin 2019

AboutBuilt from URL

Haima Therapeutics develops platelet-inspired platform technology called SYNTHOPLATE to address uncontrolled bleeding. The company focuses on creating solutions for bleeding control from medical applications to battlefield use.

ProblemBuilt from URL

Uncontrolled bleeding is a critical medical issue that needs effective treatment solutions across various settings including emergency and military situations.

See something off about this company?